Immunic presents clinical and preclinical data for imu-856 at digestive disease week 2023, including its molecular mode of action
– imu-856 is an orally available, systemically acting, highly selective and potent small molecule modulator of sirt6 – – targets regeneration of bowel epithelium and restoration of intestinal barrier function – – builds on recently released phase 1b data showing beneficial effects in celiac disease histology, disease symptoms, biomarkers and nutrient absorption – – virtual eposter to be presented today, may 6, 2023, during 9:30 am - 4:00 pm ct poster session – new york , may 6, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the presentation of clinical and preclinical data for imu-856. included in this presentation are new data on imu-856's mode of action as a potent modulator of sirt6 (sirtuin 6), a protein which serves as a transcriptional regulator of intestinal barrier function and regeneration of bowel epithelium.
IMUX Ratings Summary
IMUX Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission